90000
1-(p-Tolyl)ethanol
≥97.0% (GC)
Synonym(s):
4,α-Dimethylbenzyl alcohol, Methyl p-tolyl carbinol
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
assay
≥97.0% (GC)
form
liquid
refractive index
n20/D 1.523
bp
218-220 °C (lit.)
density
0.987 g/mL at 20 °C (lit.)
functional group
hydroxyl
SMILES string
CC(O)c1ccc(C)cc1
InChI
1S/C9H12O/c1-7-3-5-9(6-4-7)8(2)10/h3-6,8,10H,1-2H3
InChI key
JESIHYIJKKUWIS-UHFFFAOYSA-N
Storage Class
10 - Combustible liquids
wgk_germany
WGK 2
flash_point_f
224.6 °F - closed cup
flash_point_c
107 °C - closed cup
ppe
Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Carbohydrate polymers, 223, 115080-115080 (2019-08-21)
In this study, hydroxyethyl cellulose (HEC) and polyvinyl alcohol (PVA) as the framework, borax as the cross-linker, and biomass lignin from pulping black liquors and biorefinery as the plasticizer were used to synthesize the lignin-based HEC-PVA (LCP) self-healing conductive hydrogel
International journal of biological macromolecules, 137, 939-947 (2019-07-08)
The severe preparation process, poor swelling properties and mechanical properties of traditional cellulose and polyvinyl alcohol (PVA) composite hydrogels heavily limited their practical applications. To solve these issues, we use long-chain hydroxyethyl celluloses (HECs) as framework backbones, short-chain PVAs as
International journal of pharmaceutics, 596, 120213-120213 (2021-01-26)
Wound healing is a complicated process that takes a long time to complete. The three-layer nanofiber wound dressing containing melatonin is highly expected to show remarkable wound repair by reducing the wound healing time. In this study, chitosan (Cs)-polycaprolactone (PCL)/
Pharmaceutical development and technology, 26(3), 349-361 (2021-01-13)
Hypertension is one of the most common chronic cardiovascular disorders. Sustained-release formulations are developed to maintain drug therapeutic levels throughout the treatment of hypertension, to promote patient compliance and improve patient outcomes. We have developed and tested in in vivo trials
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service